Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL

This publication has 21 references indexed in Scilit:

• Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA
  Urology, 1999
• Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease
  JAMA, 1998
• Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and age
  Urology, 1996
• Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
  Published by American Medical Association (AMA) ,1995
• Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate
  Urology, 1994
• Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men
  Journal of Urology, 1994
• Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges
  JAMA, 1993
• Prostate specific antigen predominantly forms a complex with alpha1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum
  Cancer, 1992
• The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific Antigen
  Journal of Urology, 1992
• Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the Prostate
  Journal of Urology, 1991